Terms: = Head and neck cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037
7889 results:
1. Association between prognosis and lymph node status using
Ohsawa M; Hamai Y; Emi M; Ibuki Y; Kurokawa T; Yoshikawa T; Hirohata R; Kitasaki N; Okada M
World J Surg; 2024 Mar; 48(3):650-661. PubMed ID: 38686781
[TBL] [Abstract] [Full Text] [Related]
2. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
[TBL] [Abstract] [Full Text] [Related]
3. Occupation and tongue cancer in Nordic countries.
Peltonen J; Nikkilä R; Al-Samadi A; Mäkitie A; Martinsen JI; Kjaerheim K; Lynge E; Sparen P; Tryggvadottir L; Weiderpass E; Salo T; Pukkala E
BMC Oral Health; 2024 Apr; 24(1):506. PubMed ID: 38685000
[TBL] [Abstract] [Full Text] [Related]
4. Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
[TBL] [Abstract] [Full Text] [Related]
5. Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa.
Govind K; Paruk IM; Motala AA
BMC Endocr Disord; 2024 Apr; 24(1):53. PubMed ID: 38664758
[TBL] [Abstract] [Full Text] [Related]
6. Deep learning-assisted diagnosis of benign and malignant parotid tumors based on ultrasound: a retrospective study.
Jiang T; Chen C; Zhou Y; Cai S; Yan Y; Sui L; Lai M; Song M; Zhu X; Pan Q; Wang H; Chen X; Wang K; Xiong J; Chen L; Xu D
BMC Cancer; 2024 Apr; 24(1):510. PubMed ID: 38654281
[TBL] [Abstract] [Full Text] [Related]
7. Applying machine-learning models to differentiate benign and malignant thyroid nodules classified as C-TIRADS 4 based on 2D-ultrasound combined with five contrast-enhanced ultrasound key frames.
Chen JH; Zhang YQ; Zhu TT; Zhang Q; Zhao AX; Huang Y
Front Endocrinol (Lausanne); 2024; 15():1299686. PubMed ID: 38633756
[TBL] [Abstract] [Full Text] [Related]
8. Chylous leakage after esophagectomy for esophageal cancer: a systematic review.
Zheng X; Yang X; Lei S
J Cardiothorac Surg; 2024 Apr; 19(1):240. PubMed ID: 38632619
[TBL] [Abstract] [Full Text] [Related]
9. Platinum-based adjuvant chemoradiotherapy versus adjuvant radiotherapy in patients with head and neck adenoid cystic carcinoma.
Qiu Z; Wu Z; Zhou X; Lin M; Su Y; Tao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):195. PubMed ID: 38625410
[TBL] [Abstract] [Full Text] [Related]
10. Survival analysis of Sudanese oral squamous cell carcinoma patients with field of cancerization.
Eltohami Y; Suleiman A
BMC Cancer; 2024 Apr; 24(1):473. PubMed ID: 38622532
[TBL] [Abstract] [Full Text] [Related]
11. Correlation of
Ueda CE; Flausino Dias L; de Godoi Carneiro C; Sapienza MT; Alberto Buchpiguel C; Schiavom Duarte P
Arch Endocrinol Metab; 2024 Apr; 68():e230152. PubMed ID: 38602746
[TBL] [Abstract] [Full Text] [Related]
12. [Phase Ⅱ clinical trial of PD-1 inhibitor combined with chemotherapy for locally advanced resectable oral squamous cell carcinoma].
Wang HL; Yue K; Wu YS; Duan YS; Jing C; Wang XD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):335-342. PubMed ID: 38599641
[No Abstract] [Full Text] [Related]
13. Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
Cirillo A; Marinelli D; Romeo U; Messineo D; De Felice F; De Vincentiis M; Valentini V; Mezi S; Valentini F; Vivona L; Chiavassa A; Cerbelli B; Santini D; Bossi P; Polimeni A; Marchetti P; Botticelli A
BMC Cancer; 2024 Apr; 24(1):430. PubMed ID: 38589857
[TBL] [Abstract] [Full Text] [Related]
14. Characterization of parotid gland tumors using diffusion-relaxation correlation spectrum imaging: a preliminary study.
Chen W; Geng D; Xu XQ; Hu WT; Dai YM; Wu FY; Zhu LN
Clin Radiol; 2024 Jun; 79(6):e878-e884. PubMed ID: 38582630
[TBL] [Abstract] [Full Text] [Related]
15. Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation.
Pershad AR; Thakkar PG; Goodman JF; Joshi A; Steinberg SM; Allen CT; Floudas CS
Cancer Med; 2024 Apr; 13(7):e7146. PubMed ID: 38581118
[TBL] [Abstract] [Full Text] [Related]
16. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
[TBL] [Abstract] [Full Text] [Related]
17. Blood leukocytes as a non-invasive diagnostic tool for thyroid nodules: a prospective cohort study.
Wang F; Zhao D; Xu WY; Liu Y; Sun H; Lu S; Ji Y; Jiang J; Chen Y; He Q; Gong C; Liu R; Su Z; Dong Y; Yan Z; Liu L
BMC Med; 2024 Apr; 22(1):147. PubMed ID: 38561764
[TBL] [Abstract] [Full Text] [Related]
18. [The analysis of unconventional lymph node metastasis in tongue squamous cell carcinoma].
Wu K; Dai BW; Wu HJ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Mar; 59(3):227-232. PubMed ID: 38561260
[No Abstract] [Full Text] [Related]
19. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP; Tao Y; Licitra L; Burtness B; Tahara M; Rischin D; Alves G; Lima IPF; Hughes BGM; Pointreau Y; Aksoy S; Laban S; Greil R; Burian M; Hetnał M; Delord JP; Mesía R; Taberna M; Waldron JN; Simon C; Grégoire V; Harrington KJ; Swaby RF; Zhang Y; Gumuscu B; Bidadi B; Siu LL;
Lancet Oncol; 2024 May; 25(5):572-587. PubMed ID: 38561010
[TBL] [Abstract] [Full Text] [Related]
20. Diagnostic utilities of washout CYFRA 21-1 combined with washout thyroglobulin for metastatic lymph nodes in thyroid cancer: a prospective study.
Park J; An S; Kim K; Kim JS; Jung CK; Bae JS
Sci Rep; 2024 Mar; 14(1):7599. PubMed ID: 38556517
[TBL] [Abstract] [Full Text] [Related]
[Next]
